Descargar listado de publicaciones

Artículos con Factor de Impacto














Arranz FJ, Ros S, De las Cuevas C et al: Effects of comorbidity and polypharmacy
on the clinical usefulness of sertraline in elderly depressed patients: An open
multicentre study. J Affect Disord 1997, 46: 285-291. (1997 FI de 1,813 – 23/67
Q2)
De las Cuevas C, Sanz E, De la Fuente J, Cabrera C, Mateos A: Prescribed Daily
Doses and "Risk Factors" Associated with the Use of Benzodiazepines in Primary
Care. Pharmacoepidemiol Drug Saf 1999, 8(3): 207-216. (1999 FI de 0,848
114/175 Q3)
De las Cuevas C, Sanz E, Morán N, De la Fuente J:
BenzodiazepinePrescriptionisDifferent in thePublic and PrivateSectors.
PharmacoepidemiolDrugSaf 1999, 8(5): 351-353. (1999 FI de 0,848 114/175 Q3)
Livianos L, De las Cuevas C, Rojo L: El desgaste Profesional del Psiquiatra:
Resultados de una Encuesta entre Profesionales. Actas EspPsiquiatr1999,
27(5): 305-309. (1999 FI de 0,146 77/80 Q4)
De las Cuevas C, Sanz E, De la Fuente J, Padilla J, Berenguer JC: The Severity
of Dependence Scale (SDS) as screening test for Benzodiazepine
Dependence. SDS validation study. Addiction 2000, 95(2): 245-250. (2000 FI de
2,494 19/82 Q1)
De las Cuevas C, Sanz E, De la Fuente JA:Variations in Antidepressant
Prescribing Practice. ¿Clinical Need or Market Influences? Pharmacoepidemiol
Drug Saf 2002, 11 (6): 515–522. (2002 FI de 1,092 122/188 Q3)
De las Cuevas C, Sanz EJ, De la Fuente J: Benzodiazepines: More
“Behavioural” AddictionthanDependence. Psychopharmacology (Berl) 2003,
167(3): 297-303. (2003 FI de 3,429 18/87 Q1)
De las Cuevas C, Artiles J, De la Fuente J, Serrano P: Telepsiquiatría: Utopía
o Realidad Asistencial. MedClin (Barc) 2003, 121 (4): 149-52. (2003 FI de 1,08
41/102 Q2)
De las Cuevas C, Artiles J, De la Fuente J, Serrano P: Telepsychiatry in
theCanaryIslands: useracceptance and satisfaction. J TelemedTelecare2003, 9
(4): 221-224. (2003 FI de 1,094 24/53 Q2)
De las Cuevas C, Sanz EJ: Do therapeutic indications of antidepressants
change from one year to another? Pharmacoepidemiol Drug Saf 2004,
13(5): 309-314. (2004 FI de 2,098 78/187 Q2)
De las Cuevas C, Artiles J: Process Quality Analysis of Telepsychiatry.
Contributions of Statistical Control Process and Critical Pathway Analysis.
Neuropsychiatrie 2004, 18 S2: 100-105. (2004 FI de 1,414 56/90 Q3)
De las Cuevas C, González de Rivera JL: Some considerations about the
concept of presence in telepsychiatry. Neuropsychiatrie 2004, 18 S2: 112-115.
(2004 FI de 1,414 56/90 Q3)
Sanz EJ, De las Cuevas C, Kiuru A, Bate A, Edwards R:Selective serotonin
reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a
database analysis. Lancet 2005, 365: 482-487. (2005 FI de 23,78 2/105 Q1)
De las Cuevas C, Sanz EJ, De la Fuente J, Cueto M: La Polimedicación de los
Pacientes Psiquiátricos como Alternativa a la Escasez de Recursos
Asistenciales. Polypharmacy in psychiatric patients as an alternative to limited
mental health resources. ActasEspPsiquiatr. 2005 Mar; 33(2):81-86. (2005 FI
de 0,286 88/94 Q4)

De las Cuevas C, Sanz EJ: Polypsychopharmacy. A Frequent and Debatable
Practice in Psychiatric Inpatients. J ClinPsychopharmacol 2005, 25(5): 510-512.
(2005 FI de 5,145 6/94 Q1)

De las Cuevas C, Arredondo MT, Cabrera MF, Sulzenbacher H, Meise U.
Randomized Clinical Trial of Telepsychiatry through Videoconference versus
Face-to-Face Conventional Psychiatric Treatment. Telemed J E Health 2006,
12(3): 341-350. (2006 FI de 0,816 48/57 Q4)
Sulzenbacher H, Bullinger AH, De las Cuevas C, Meise U.Psychiatry in the
internet and the internet in psychiatry - A new medium and itsimpact. Die
Psychiatrie im Internet und das Internet in der Psychiatrie – ein neues Médium
und seine Auswirkungen. Neuropsychiatrie, 2006 20 (4): 273-278. (2006 FI de
1,722 61/94 Q3)












De las Cuevas C, Sanz EJ. Duloxetine-induced excessive disturbing and
disabling yawning. J ClinPsychopharmacol 2007, 27(1): 106-107. (2007 FI de
3,878 20/94 Q1)
De las Cuevas C, Álvarez de la Rosa M, Troyano JM, Sanz EJ. Are
Psychotropics Drugs Used in Pregnancy? Pharmacoepidemiol Drug Saf 2007,
16(9): 1018-1023. (2007 FI de 2,475 77/205 Q2)
De las Cuevas C, Sanz EJ. Attitudes towards Psychiatric Drug Treatment. The
Experience of Being Treated: Eur J ClinPharmacol2007, 63(11):1063-7. (2007
FI de 2,177 98/205 Q2)
González-Saiz F, De las Cuevas C, Barrio G, Domingo-Salvany A. Spanish
Version of the Severity of Dependence Scale (SDS). Med Clin (Barc) 2008,
131: 797-8. (2008 FI de 1,258 62/107 Q3)
De las Cuevas C, Sanz EJ. Enfermedad Mental y Seguridad Vial. Actas
EspPsiquiatr 2009 37(2): 75-81. (2009 FI de 0,515 101/107 Q4)
Serrano P, Ramallo Y, Trujillo MM, Muñoz SR, Perestelo L,De las Cuevas C.
The Relationship among Mental Health Status (GHQ-12), Health Related
Quality of Life (EQ-5D) and Health-state Utilities in a General Population.
EpidemiolPsichiatr Soc. 2009 Jul-Sep;18(3): 229-39. (2009 FI de 1,860 41/94
Q2)
De las Cuevas C, Ramallo Y, Sanz EJ. Psychomotor Performance and Fitness
to Drive: The Influence of Psychiatric Disease and its Pharmacological
Treatment. Psychiatry Research 2010, 176 (2-3): 236-241. (2010 FI de 2,803
44/128 – Q2)
De las Cuevas C,Rivero-Santana A, Perestelo-Pérez L, González-Lorenzo M,
Pérez-Ramos J, Sanz EJ. Adaptation and Validation Study of the Beliefs about
Medicines Questionnaire in Psychiatric Outpatients in a Community Mental
Health Setting. Hum. PsychopharmacolClinExp 2011; 26: 140–146. (2011 FI de
2,476 29/75 – Q2)
De las Cuevas C, Ramallo Y, Sanz EJ. ¿Están relacionadas la obesidad y otras
comorbilidades físicas con la enfermedad mental? RevPsiquiatr Salud Ment
(Barc.). 2011, 4(3): 119-125. (2011 FI de 0,308 110/117 – Q4)
De las Cuevas C, Rivero A, Perestelo-Pérez L, González M, Pérez J, Peñate
W. Psychiatric Patients’ Attitudes towards Concordance and Shared Decision
Making. Patient Education and Counseling 2011, 85: e245-e250. (2011 FI de
2,305 49/158 – Q2)
De las Cuevas C., Ramallo Y, Sanz EJ.. Are Obesity and other Physical
Comorbidities related to Mental Illness? Revista de Psiquiatría y Salud Mental
(Barc). 2011, 4(3):119-125. (2011 FI de 0,308 110/117 – Q4)

De las Cuevas C, Rivero-Santana A, Perestelo-Pérez L, Pérez-Ramos J,
Gonález-Lorenzo M, Serrano-Aguilar P, Sanz EJ. Mental Health Professionals’
Attitudes to Partnership in Medicine Taking: a validation study of Leeds Attitude
to Concordance Scale II. Pharmacoepidemiol Drug Saf2012, 21: 123–129.
(2012 FI de 2,897 81/261 – Q2)

Rodríguez-Hernández PJ, Betancort M, Ramírez-Santa GM, Sanz-Álvarez, EJ,
De las Cuevas-Castresana C. Psychometricproperties of theparent and
teacherversions of theStrength and DifficultiesQuestionnaire (SDQ) in a
Spanishsample. International Journal of Clinical and Health Psychology 2012,
12 2: 265-279. (2012 FI de 2,102 33/114 – Q2)
De las Cuevas C, Rivero-Santana A, Perestelo-Pérez L, Serrano-Aguilar P.
AttitudestowardConcordance in Psychiatry: A comparative, cross-sectionalstudy
of psychiatricpatients and mental healthprofessionals. BMC Psychiatry 2012,
12:53. (2012 FI de 2,233 64/135 – Q2)







Mahtani-Chugani V, Sanz-Alvarez E, De las Cuevas-Castresana C.
[Antidepressantmanagementstrategyfromthepatientperspective:
Strugglinginternally and externally] AtenPrimaria. 2012 Aug;44(8):463-70. (2012
FI de 0,957 86/155 – Q3)
Rivero-Santana A, Perestelo-Perez L, Pérez-Ramos J, Serrano-Aguilar P, De
las Cuevas C. Socio-demographic and clinical predictors of compliance with
antidepressants for depressive disorders. A systematic review of observational
studies. Patient Preference and Adherence 2013, 7: 151–169. (2013 FI de
1,491 71/151 – Q2)
De las Cuevas C, Peñate W, Sanz EJ. Psychiatric outpatients’ self-reported
adherence versus psychiatrists’ impressions on adherence in Affective
Disorders. Hum. PsychopharmacolClinExp 2013; 28: 142–150. (2013 FI de
1,854 75/135 – Q3)
De las Cuevas C, Peñate W, Perestelo-Pérez L, Serrano-Aguilar P. Shared
Decision-Making in Psychiatric Practice and the Primary Care Setting is by no
means the same, according to SDM-Q-9. Neuropsychiatric Disease and
Treatment 2013, 9: 1045-1052. (2013 FI de 2,154 68/135 – Q3)
De las Cuevas C, Peñate W, Sanz EJ. Risk factors for non-adherence to
antidepressant treatment in patients with mood disorders. Eur J ClinPharmacol
2014, 70: 89–98. (2014 FI de 2,966 84/254 – Q2)
De las Cuevas C, Peñate W, De Rivera L. Psychiatric patients’ preferences and
experiences in clinical decision-making: Examining concordance and correlates
of patients' preferences. Patient Education and Counseling 2014, 96(2): 222228. (2014 FI de 2,199 57/162 – Q2)

De las Cuevas C, Peñate W, Betancort M, De Rivera L. Psychological
reactance in psychiatric patients: Examining the dimensionality and correlates
of the Hong Psychological Reactance Scale in a large clinical sample.
Personality and Individual Differences2014, 70: 85-91.(2014 FI de 1,951 19/62
– Q2)

De las Cuevas C, Peñate W, Sanz EJ. The relationship of psychological
reactance, health locus of control and sense of self-efficacy with adherence to
treatment in psychiatric outpatients with depression. BMC Psychiatry
2014,14:324 doi:10.1186/s12888-014-0324-6. (2014 FI de 2,210 71/140– Q3)

De las Cuevas C, Peñate W. To what extent psychiatric patients perceive
involvement in decision-making about their mental health care? Relationships
with socio-demographic, clinical and psychological variables. ActaNeurpsychiatr
2014, 26(6): 372-381. (2014 FI de 0,802 119/140 – Q4)

De las Cuevas C, Peñate W, De Rivera L. To what extent is treatment
adherence of psychiatric patients influenced by their participation in shared
decision-making? Patient Preference and Adherence 2014, 8 1547–1553.
(2014 FI de 1,676 59/154 – Q2)

De las Cuevas C, Peñate W, Betancort M, Cabrera C. What do psychiatric
patients believe regarding where control over their illness lies? Validation of the
Multidimensional Health Locus of Control Scale in psychiatric outpatient care. J
NervMent Dis. 2015, Feb;203(2):81-6.(2014 FI de 1,688 90/140 – Q3)

De las Cuevas C, Peñate W. Psychometric Properties of the eight-Item Morisky
Medication Adherence Scale (MMAS-8) in Psychiatric Outpatient Setting.
International Journal of Clinical and Health Psychology 2015, 15: 121-129.
(2014 FI de 2,850 23/119 – Q1)

De las Cuevas C, Peñate W. Explaining pharmacophobia and pharmacophilia
in
psychiatric
patients:
Relationship
with
treatment
adherence.
HumPsychopharmacolClinExp 2015, 30(5); 377-383. (2014 FI de 2,192 33/76 –
Q2)

De las Cuevas C, Peñate W. Perceived Self-Efficacy and Mental Illness:
Validation of the General Self-efficacy Scale in Psychiatric Outpatient Care.
Psicothema 2015, Vol. 27, No. 4, 410-415. (2014 FI de 1,210 58/129 – Q2)

De las Cuevas C, Perestelo-Perez L, Rivero-Santana A, Cebolla-Martí A, Scholl
I, Härter M. Validation of the Spanish version of the 9-item Shared Decision
Making Questionnaire. Health Expectations 2015, 18(6): 2143-2153.(2014 FI de
3,410 5/71 – Q1)

Lara-Cabrera ML, Salvesen O, Nesset MB, De las Cuevas C, Cabral V, Gråwe
RW. The effect of a brief educational program added to mental health treatment
to improve patient activation: A randomized controlled trial in two Community
Mental Health Centres. Patient Education and Counseling 2016, 99(5): 760768. (2014 FI de 2,199 57/165 – Q2)

De las Cuevas C, Marrero R, Cabrera C. Treatment-related decisional conflict
in patients with depressive and anxious disorders. Patient Preference and
Adherence 2016 (accepted 15 april 2016, will be published June issue.(2014 FI
de 1,676 59/154 – Q2)

De las Cuevas C, Peñate W, Cabrera C. Perceived health control: A promising
step forward in our understanding of treatment adherence in psychiatric care.
The Journal of Clinical Psychiatry 2016 (accepted 24 september, 2015- will be
published in July issue). (2014 FI de 5,498 18/140 – Q1)